Circassia Limited: Clinical Trials

37 trials sponsored by Circassia Limited, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed, 1 terminated, 1 withdrawn. 20 Phase 2, 4 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 220Completed 19, Withdrawn 1
Phase 14Completed 4
Phase 33Completed 2, Withdrawn 1

Follow Circassia Limited: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Grass-SPIRE Registration Study
Grass-SPIRE, Placebo - Rhinitis, Conjunctivitis
Phase 2 / Phase 3WithdrawnCircassia Limited2016-05-012016-06-23
Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America
Blood Sampling - Allergy
TerminatedAdiga Life Sciences, Inc.1992015-10-012019-04-09
Birch-SPIRE Safety and Efficacy Study
Birch-SPIRE, Placebo - Rhinitis
Phase 2CompletedCircassia Limited642015-07-012016-11-08
Ragweed-SPIRE Follow-On Study
Rhinoconjunctivitis, Ragweed Allergy
CompletedCircassia Limited2492015-04-012016-03-23
A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy
Cat-PAD, Placebo - Cat Allergy, Cat Hypersensitivity
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)392015-03-092018-11-02
Phase II HDM-SPIRE Safety and Efficacy Study
HDM-SPIRE, Placebo - Rhinoconjunctivitis
Phase 2CompletedCircassia Limited7152014-09-012018-06-15
ToleroMune Grass Follow on Study
Rhinoconjunctivitis, Grass Allergy
CompletedCircassia Limited842014-04-012014-11-17
Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma
Grass-SPIRE, Placebo - Seasonal Allergic Rhinitis, Asthma
Phase 2CompletedCircassia Limited542014-04-012015-03-24
Grass Observational Study
Grass Allergy, Rhinoconjunctivitis
CompletedCircassia Limited1092014-04-012015-04-08
Phase III Cat-PAD Follow-on Study
Received Cat-PAD Treatment 1 in Study CP007 [NCT01620762], Received Cat-PAD Treatment 2 in Study CP007 [NCT01620762], Received Cat-PAD Treatment 3 in Study CP007 [NCT01620762] - Cat Allergy
Phase 3CompletedCircassia Limited4302014-02-012018-06-15
Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber
Ragweed-SPIRE, Placebo - Seasonal Allergic Rhinitis
Phase 2CompletedCircassia Limited2802014-01-012015-03-20
Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma
Ragweed-SPIRE, Placebo - Seasonal Allergic Rhinitis, Asthma
Phase 2CompletedCircassia Limited552014-01-012015-01-21
House Dust Mite Observational Study
Rhinoconjunctivitis
CompletedCircassia Limited1002013-09-012014-05-15
An Optional Investigation of Biomarkers of Efficacy
Rhinoconjunctivitis
CompletedCircassia Limited1052013-09-012014-05-21
ToleroMune House Dust Mite (HDM) Tolerability Study
ToleroMune HDM, Placebo - Rhinoconjunctivitis
Phase 2CompletedCircassia Limited302013-09-012014-06-11
ToleroMune House Dust Mite Follow on Study
House Dust Mite Allergy, Rhinoconjunctivitis
CompletedCircassia Limited1052013-09-012014-05-15
Paediatric Safety Study in Cat-PAD
Cat-PAD, Placebo - Rhinoconjunctivitis
Phase 2CompletedCircassia Limited162013-08-012018-05-14
ToleroMune Grass Follow on Study
Grass Allergy, Rhinoconjunctivitis
CompletedCircassia Limited1632013-05-012013-11-26
Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris
SPS4251 Ointment, Placebo, Daivonex® ointment - Psoriasis Vulgaris
Phase 1CompletedCircassia Limited242013-03-012013-07-17
Phase III Cat-PAD Study
Cat-PAD, Placebo - Rhinoconjunctivitis
Phase 3CompletedCircassia Limited14082012-10-012018-06-15

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Hypersensitivity (9)  ·  Rhinitis (5)  ·  Rhinitis, Allergic, Seasonal (3)  ·  Asthma (2)  ·  Dust Mite Allergy (2)  ·  Conjunctivitis (1)

Interventions

Blood Specimen Collection (1)  ·  calcipotriene (1)

Countries

Canada (27)  ·  United States (6)  ·  Germany (4)  ·  Poland (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Chile (1)  ·  Czechia (1)  ·  France (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Slovakia (1)  ·  South Africa (1)

Top investigators

Deepen Patel, MD, CCFP (3)  ·  Jacques Hebert, MD (3)  ·  Peter Couroux, MD (3)  ·  Amarjit Cheema, MD (1)  ·  Anne K Ellis, MD MSC FRCPC (1)  ·  David Bernstein, MD (1)  ·  Deepen Patel, MD (1)  ·  Deepen Patel, MD, CCF (1)  ·  Harold Nelson, MD (1)  ·  Helen Neighbour (1)  ·  Margitta Worm, MD Professor (1)  ·  Piyush Patel, MD (1)

Results publications

PMID 29682277, PMID 31568796

NIH funding

U19AI100266 (1)